TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | ¥19 | ¥18 | ¥16 | ¥17 |
| % Growth | 1% | 17.6% | -10.2% | – |
| Cost of Goods Sold | ¥6 | ¥6 | ¥7 | ¥3 |
| Gross Profit | ¥12 | ¥12 | ¥9 | ¥14 |
| % Margin | 66.2% | 67.8% | 56.1% | 81.8% |
| R&D Expenses | ¥1 | ¥0 | ¥1 | ¥1 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥2 |
| SG&A Expenses | ¥4 | ¥3 | ¥4 | ¥2 |
| Sales & Mktg Exp. | ¥4 | ¥3 | ¥4 | ¥0 |
| Other Operating Expenses | -¥1 | ¥1 | -¥1 | ¥0 |
| Operating Expenses | ¥4 | ¥4 | ¥4 | ¥3 |
| Operating Income | ¥8 | ¥8 | ¥5 | ¥11 |
| % Margin | 44.4% | 43.6% | 31.7% | 64.1% |
| Other Income/Exp. Net | -¥0 | -¥0 | -¥0 | -¥3 |
| Pre-Tax Income | ¥8 | ¥8 | ¥5 | ¥8 |
| Tax Expense | ¥2 | ¥2 | ¥2 | ¥3 |
| Net Income | ¥6 | ¥6 | ¥3 | ¥4 |
| % Margin | 33.9% | 31.3% | 19.4% | 25.7% |
| EPS | 62.07 | 57.74 | 30.35 | 44.81 |
| % Growth | 7.5% | 90.2% | -32.3% | – |
| EPS Diluted | 58.9 | 57.74 | 30.35 | 44.81 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥1 | ¥1 | ¥1 | ¥1 |
| EBITDA | ¥9 | ¥9 | ¥5 | ¥9 |
| % Margin | 48.4% | 46.9% | 33.9% | 49% |